Blanc, L., Sarathy, J. P., Alvarez Cabrera, N., O’Brien, P., Dias-Freedman, I., Mina, M., . . . Dartois, V. (2018). Impact of immunopathology on the antituberculous activity of pyrazinamide. J Exp Med.
シカゴスタイル引用形Blanc, Landry, et al. "Impact of Immunopathology On the Antituberculous Activity of Pyrazinamide." J Exp Med 2018.
MLA引用形式Blanc, Landry, et al. "Impact of Immunopathology On the Antituberculous Activity of Pyrazinamide." J Exp Med 2018.
警告: この引用は必ずしも正確ではありません.